HARMONY BIOSCIENCES HOLDINGS, INC. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $69.59 million as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2024-02-22
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $69.59M.
- 2023-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $67.84M.
- 2023-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $74.15M.
- 2023-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $77.33M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2023-12-31 | $69.59M 10-K · filed 2024-02-22 |
| 2023-09-30 | $67.84M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $74.15M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $77.33M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $83.56M 10-K · filed 2023-02-21 |
| 2022-09-30 | $83.98M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $90.38M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $95.57M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $56.53M 10-K · filed 2022-02-28 |
| 2021-09-30 | $63.45M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |